The Potential Role of an Artificial Intelligence-Driven Tool in Decision-Making for Mitral Valve Repair Surgery
<b>Background:</b> Annuloplasty ring sizing is critical for durable outcomes in surgical mitral valve repair (MVr). However, there is no clear consensus on optimal sizing strategies. Artificial intelligence (AI)-based imaging tools may help to reduce uncertainty in preoperative decision-making by providing objective, reproducible and reliable measurements. This study evaluated the predictive capability of a fully automated, computed tomography (CT)-based AI-driven tool for annuloplasty ring sizing in patients undergoing minimally invasive MVr (MI-MVr). <b>Methods:</b> A total of 71 consecutive patients undergoing MI-MVr for Carpentier type II mitral valve insufficiency during the study period were included. Preoperative CT scans were analyzed using a cloud-based, fully automated AI tool to quantify mitral valve geometric parameters. Correlations between AI-derived measurements and implanted ring sizes were assessed using the Pearson correlation test. Univariable and multivariable linear regression analyses were performed to identify independent predictors of ring size selection. <b>Results:</b> Several AI-derived parameters correlated significantly with implanted ring size, with the strongest correlations observed for commissural width (R = 0.693, <i>p</i> < 0.001) and mitral annular area (R = 0.693, <i>p</i> < 0.001). In multivariable regression analysis, these parameters were the strongest predictors of annuloplasty ring size (R<sup>2</sup> = 0.504, <i>p</i> < 0.001). Using this model, accurate annuloplasty ring sizing could be predicted in 78.8% of patients. There were no in-hospital mortality and residual mitral regurgitation at discharge. <b>Conclusions:</b> A fully automated, CT-based AI-driven tool demonstrated good accuracy for preoperative annuloplasty ring size prediction in MI-MVr and may have the potential to support surgical decision-making, reduce operator dependence, and improve reproducibility.
Authors
- Jörg Kempfert (ORCID: https://orcid.org/0000-0002-2009-6375)
- Simon Sündermann (ORCID: https://orcid.org/0000-0003-4927-1584)
- Stephan Jacobs (ORCID: https://orcid.org/0000-0001-7353-1855)
- Serdar Akansel (ORCID: https://orcid.org/0000-0002-3479-4537)
- Martina Dini (ORCID: https://orcid.org/0009-0000-6249-8877)
- V. Falk
- Markus Kofler
- Emilija Myskinite
Institutions
- ETH Zurich (CH)
- Deutsches Herzzentrum der Charité (DE)
- German Centre for Cardiovascular Research (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- Journal of Clinical Medicine
- Published
- 2026-03-17
- DOI
- https://doi.org/10.3390/jcm15062300
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00